All In Biotech

Drug Trial Radar · NCT02279745

Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension

An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension

Last checked: Nov 19, 2026Latest source record: Dec 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

45

Actual

Start

Jul 8, 2015

Primary completion

Mar 29, 2021

Study completion Mar 29, 2021

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 31, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study was an open-label extension study to determine the long-term safety and tolerability of ralinepag in subjects with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) who have completed Study APD811-003, or who were assigned to receive placebo and were discontinued due to clinical worsening.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • RalinepagDrug

    Active

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Pulmonary Vascular ResistanceTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
  2. Change From Baseline in Cardiac OutputTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
  3. Change From Baseline in Cardiac IndexTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
  4. Change From Baseline in Mean Pulmonary Arterial PressureTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.

Locations

46 sites in 10 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Cedars-Sinai Medical Center

    Beverly Hills, California

  • David Geffen School of Medicine at UCLA

    Los Angeles, California

  • University of California Davis Medical Center

    Sacramento, California

  • Harbor-UCLA Medical Center

    Torrance, California

  • University of Colorado Cardiac and Vascular Center, Anschutz Inpatient Pavilion

    Aurora, Colorado

  • Cleveland Clinic Florida

    Weston, Florida

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Chest Medicine Associates

    Portland, Maine

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Boston University Medical Center General Clinical Research Unit (GCRU)

    Boston, Massachusetts

  • University of Michigan Health System

    Ann Arbor, Michigan

  • UC Health

    Cincinnati, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion

    Columbus, Ohio

  • UPMC, Presbyterian

    Pittsburgh, Pennsylvania

  • UT Southwestern Medical Center

    Dallas, Texas

  • Memorial Hermann Hospital - Texas Medical Center

    Houston, Texas

  • Fiona Stanley Hospital

    Murdoch, Australia

  • St. Vincent's Hospital

    Darlinghurst, New South Wales, Australia

  • The Prince Charles Hospital

    Chermside, Queensland, Australia

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

  • St Vincent's Hospital

    Fitzroy, Victoria, Australia

  • Multiprofile Hospital for Active Treatment "National Heart Hospital" EAD, Clinic of Cardiology

    Sofia, Bulgaria

  • Multiprofile Hospital for Active Treatment " St. Anna", Sofia AD, Cardiology Clinic

    Sofia, Bulgaria

  • Department of Internal Medicine I - Cardiology, University Hospital Olomouc

    Olomouc, Czechia

  • Second Internal Clinic - Clinic of Cardiology and Angiology, 1st Faculty of Medicine, Charles University in Prague, General University Hospital in Prague

    Prague, Czechia

  • Gottsegen Gyorgy Orszagos Kardiológiai lntézet - National Institute of Cardiology, Department of Adult Cardiology

    Budapest, Hungary

  • Semmelweis University, Department of Pulmonology - Semmelweis Egyetem Pulmonológiai Klinika

    Budapest, Hungary

  • University of Szeged Faculty of Medicine, 2nd Department of Medicine and Cardiology Center, Albert Szent-Györyi Clinical Center - SZTE ÁOK Szent-Györgyi A lbert Klinikai Központ I I. sz. Belgyógyászati Klini ka és Kard ilógiai Központ

    Budapest, Hungary

  • University of Pecs, Medical School, Heart Institute - Pécsi Tudományegyetem, Klinikai Központ, Szívgyógyászati Klinika

    Budapest, Hungary

  • University of Derecen Clinical Research Center Cardiology and Cardiac Surgery Department - Debreceni Egyetem Klinikai Kozpont Kardiologiai es Szivsebeszeti Klinika

    Debrecen, Hungary

  • Medical University of Bialystok Clinical Hospital Cardiology Clinic - Uniwersytecki Szpital Kliniczny, Klinika Kardiologii z Oddziałem Intensywnego Nadzoru Kardiologicznego

    Krakow, Poland

  • John Paul II Hospital in Cracov Department of Cardiac and Vascular Diseases - Krakowski Szpital Specjalistyczny im. Jana Pawła II, Oddział Kliniczny Chorób Serca i Naczyń

    Krakow, Poland

  • Biegański Provincial Specialist Hospital Department of Cardiology - Wojewódzki Szpital Specjalistyczny im. dr Wł. Biegańskiego w Lodzi, Oddział Kardiologiczny

    Lodz, Poland

  • "Prof. Dr. C.C. Iliescu" Institute of Cardiovascular Diseases, Department of Clinic Cardiology III - Institutul de Urgenţă pentru Boli Cardiovasculare "Prof. Dr. C.C. Iliescu", Secţia Clinica Cardiologie fIJ

    Bucharest, Romania

  • "Marius Nasta" Institute of Pneumoftiziology, Department of Pneumoftiziology IV - Institutul de Pneumoftiziologie "Marius Nasta", Sectia Clinica Pneumoftiziologie IV

    Bucharest, Romania

  • "Dr. Victor Babes" Clinic Hospital for Infesctious Diseases and Pneumoftiziology, Department of Clinic Pneumology II

    Timișoara, Romania

  • Clinical Centre of Serbia (CCS), Cardiology Clinic - Klinicki Centar SrЬije, Klinika za kardiologiju

    Belgrade, Serbia

  • Кlinicko-bolnicki Centar Zemun, Кlinika za internu medicinu, Sluzba za kardiologiju

    Belgrade, Serbia

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.